Company Profile
ABVC BioPharma, Inc. Stock Price, News & Catalysts
- Ticker:
- ABVC
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States and trades on NASDAQ, placing it in the small-cap biotech category
Stock performance
1.02 USD (-3.77%)
Close
Last updated: October 1, 2026
32.5M USD
Market cap
Why the stock is moving
As of Oct 1, 2026, ABVC closed down 3.77% at $1.02. No new same-company headline was identified in the current news window.
Company overview
Botanical Drug and Medical Device Developer
ABVC BioPharma develops drug candidates and medical devices originating from botanical compounds and academic research. The portfolio spans central nervous system disorders, oncology, ophthalmology, and women's health.
ABV-1505 for Adult ADHD
ABV-1505 is a botanical drug candidate being studied for adult attention-deficit hyperactivity disorder. The program is intended to offer a non-stimulant treatment approach through a standardized extract and regulated clinical-development pathway.
Vitargus Vitreous Substitute
Vitargus is a bioengineered hydrogel being developed as a vitreous substitute for retinal surgery. The material is designed to maintain the space and optical properties of the eye after removal of the natural vitreous.
Oncology and Additional Programs
The pipeline includes ABV-1519 for non-small cell lung cancer and other botanical candidates licensed from research institutions. Development is conducted through subsidiaries, academic collaborations, and regional clinical partners.
BioFirst Structure
ABVC has organized several development assets through BioFirst and related entities. This structure can support separate financing, partnering, or strategic transactions around individual programs.
Future catalysts
Recent news
- 01
- 02
- 03
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of ABVC BioPharma, Inc. (ABVC)?
ABVC BioPharma, Inc. (ABVC) most recently closed at 1.02 USD, a -3.77% move versus the previous session.
What is the market cap of ABVC BioPharma, Inc. (ABVC)?
ABVC BioPharma, Inc. currently has a market capitalization of 32.5M USD on BioPharmSignal.
What does ABVC BioPharma, Inc. do?
Botanical Drug and Medical Device Developer ABVC BioPharma develops drug candidates and medical devices originating from botanical compounds and academic research. The portfolio spans central nervous system disorders, oncology, ophthalmology, and women's health. ABV-1505 for Adult ADHD ABV-1505 is a botanical drug candidate being studied for adult...
On which exchange is ABVC stock listed?
ABVC BioPharma, Inc. (ABVC) is associated with NASDAQ, United States and trades on NASDAQ, placing it in the small-cap biotech category, Biopharma.
What is ABV-1505?
ABV-1505 for Adult ADHD ABV-1505 is a botanical drug candidate being studied for adult attention-deficit hyperactivity disorder.
Which conditions is ABVC BioPharma, Inc. targeting with ABV-1505?
ABVC BioPharma, Inc. is associated with oncology, cancer therapeutics, ophthalmology based on its company overview and current catalyst commentary.
What is ABV-1519?
Oncology and Additional Programs The pipeline includes ABV-1519 for non-small cell lung cancer and other botanical candidates licensed from research institutions.
What is Botanical?
Botanical Drug and Medical Device Developer ABVC BioPharma develops drug candidates and medical devices originating from botanical compounds and academic research.